DHANUKA Dhanuka Agritech Q4 FY25 results (Jan–Mar 2025) and concall
Dhanuka Agritech delivered strong financial results for Q4 and FY25, achieving record revenue and significant margin expansion. The company made a strategic move into global markets with the acquisition of international rights for two fungicide molecules. While the Dahej plant remains a drag on profitability, management is optimistic about future growth driven by new product launches and a favorable monsoon, despite anticipated gross margin pressures from raw material costs.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 654 | 445 | 442 |
| EBITDA | 160 | 76 | 110 |
| Net profit | 118 | 55 | 76 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
